ARCHIVES

Senate Investigates Opioid Manufacturers, Requests Study of Impact of DEA Policies

This article is from The Cancer Letter archive.

Vol. 38 No. 19 | May 11, 2012

Download PDF Visit The Full Archive

Related Articles

Includes April issue of Business & Regulatory Report (8 pages).

May 2, 2003

The Avastin Story In A Nutshell: A Timeline

May 27, 2011

In Brief: Resolution wasn’t Strong Enough, Reizen Though; Two More chemicals reported Out of Bioassay

June 3, 1977

Conferess Ok $10.9 Bil. NIH Bidget, OAM to Get $3.5 Million

October 15, 1993

Comments Invited On Centers Program

November 27, 1987

Irinotecan And Carboplatin Improve Response In NSCLC

June 24, 2005